Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study
INTRODUCTION: As a new index of obesity and metabolism, the cardiometabolic index (CMI) has been shown to play an important role in the prediction and diagnosis of metabolic diseases. However, the relationship between CMI and osteoporosis (OP) in type 2 diabetes mellitus (T2DM) patients with metabol...
Saved in:
| Main Authors: | Yangyang Zhang, Jinyang An, Xinsai Li, Lingling Li, Jia Bai, Haihong Lv |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2025-08-01
|
| Series: | Endokrynologia Polska |
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/endokrynologia_polska/article/view/105133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is there an association between osteoporosis and uric acid?
by: N. V. Toroptsova, et al.
Published: (2024-12-01) -
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
Effect of canagliflozin combined with alfacalcidol in the treatment of elderly type 2 diabetes mellitus with osteoporosis
by: HUANG Yi*,JIANGXiong,PENG Jun,GUI Xiao,LIU Shuang,LI Peng,LI Yanling,JIANG Meiling
Published: (2025-07-01) -
Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis
by: Peng Su, et al.
Published: (2025-07-01) -
Restoring the Architecture: A Rapid Clinical Perspective on Bone-Mineral Density and Osteoporosis
by: Linda Brand, et al.
Published: (2017-12-01)